IL17C and inflammatory bowel disease: Gut inflammation–Human/patient data: IL-17C expression is enhanced in the intestinal tissues from active IBD patients (102, 103)–Animal models: IL-17C participates in mucosal responses to Citrobacter rodentium, promotes intestinal barrier functions, and protects from DSS-induced colitis (96, 97, 101)